Splenectomy: Clinical Trials

9 trials of Splenectomy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 1 recruiting, 1 terminated. 2 Not applicable, 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Terminated 1
Phase 32Completed 1, Unknown 1
Phase 21Unknown 1

Follow Splenectomy: new trials by email Literature Review of Splenectomy trials Research Report on Splenectomy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Splenectomy on Debridement for Acute Necrotizing Pancreatitis With Pancreatic Sinistral Portal Hypertension
Splenectomy, Control - Acute Necrotizing Pancreatitis, Portal Hypertension
Not applicableRecruitingZhejiang University662025-07-302025-07-23
PREDIGA 2: Spanish Acronym of "Educational and Diagnostic Project for Gaucher and ASMD"
Patient with splenomegaly or splenectomy - Gaucher Disease, Acid SphingoMyelinase Deficiency
CompletedFundación Española de Hematología y Hemoterapía1222023-03-212026-02-19
Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
splenectomy - Thrombocytopenia, Splenectomy
UnknownInstitute of Hematology & Blood Diseases Hospital, China502019-01-232025-02-24
Microbiota is Related With Increasing Infection Rates After Splenectomy
splenectomy - Gut Microbiota, Spleen Injury
UnknownFirst Affiliated Hospital of Harbin Medical University802017-05-012019-02-25
Splenectomy During Whole Liver Transplantation
Splenectomy - End Stage Liver Disease
CompletedHospices Civils de Lyon1412015-01-012018-08-01
Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology
splenectomy - Hemophagocytic Lymphohistiocytosis
Phase 2 / Phase 3UnknownBeijing Friendship Hospital302015-01-012016-08-10
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Second Line ITP agents - Immune Thrombocytopenia
CompletedBoston Children's Hospital1202013-08-012020-05-21
Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
Radical Antegrade Modular Pancreatectomy with Splenectomy, Radical Antegrade Modular Pancreatectomy without splenectomy - Left-sided Pancreatic Cancer, Ductal Adenocarcinoma
Not applicableTerminatedYonsei University12013-04-012016-11-22
Comparison Between Open and Laparoscopic Splenic Aneurysms Repair
Laparoscopic splenic aneurysm repair, eventual splenectomy, Laparotomic splenic artery aneurysm repair, eventual artery reconstruction or splenectomy - Splenic Artery Aneurysm
Phase 3CompletedAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia292001-01-012011-07-07

Conditions studied

Thrombocytopenia (2)  ·  Aneurysm (1)  ·  Autoimmune Diseases (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Platelet Disorders (1)  ·  End Stage Liver Disease (1)  ·  Gaucher Disease (1)  ·  Hematologic Diseases (1)  ·  Hemorrhage (1)  ·  Hemorrhagic Disorders (1)  ·  Hypertension, Portal (1)  ·  Immune System Diseases (1)  ·  Infections (1)  ·  Lymphohistiocytosis, Hemophagocytic (1)  ·  Niemann-Pick Diseases (1)

Sponsors

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (1)  ·  Beijing Friendship Hospital (1)  ·  Boston Children's Hospital (1)  ·  First Affiliated Hospital of Harbin Medical University (1)  ·  Fundación Española de Hematología y Hemoterapía (1)  ·  Hospices Civils de Lyon (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Yonsei University (1)  ·  Zhejiang University (1)

Countries

China (4)  ·  Canada (1)  ·  France (1)  ·  Italy (1)  ·  South Korea (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Guido AM Tiberio, MD (1)  ·  Lei Zhang, MD (1)  ·  Wei Yunwei (1)

Results publications

PMID 29659042, PMID 30945320